Through the power of engineered cell therapy, we have the potential to revolutionize cancer treatment and bring hope to millions of patients worldwide. But true success lies not only in the science but also in the leadership that guides it. In this episode, we have the pleasure of having Dr. Michael Hudecek, a distinguished researcher and academic coordinator of the T2Evolve project. Michael has been instrumental in spearheading the development of CAR-T cell therapy, one of the most promising treatments for cancer patients. Our conversation with Michael delves into his research, discussing the latest advancements and discoveries in the field of CAR-T therapy. But that's not all. Dr. Hudecek also shares his insights on what it takes to be an effective leader of a lab group and how to lead a successful team with the right skills. Join us as we explore the world of engineered cell therapy and gain valuable insights from one of the leading researchers in Europe.